官方服务：
资源简介：
ATAC-seq and RNA-seq integrated analysis was used to elucidate the antitumour mechanism of p300 inhibitor-B029-2 in HCC
应用场景：
创建时间：
2020-03-23
相关数据集
Feasibility of marker-less stereotactic body radiotherapy for hepatocellular carcinoma
The feasibility of marker-less stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC) has not yet been established, and, thus, was examined in the present study. We retrospectively i
Figshare2021-11-17 更新50
Additional file 2 of The epitome of tailor-made short positively charged peptides against HCC via integrated pharmacology
Additional file 2: Table S2. The profiling of key targets in this study.
NIAID Data Ecosystem20
Therapeutic efficacy and safety of percutaneous microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a systematic review
Systematic review protocol registration
DataCite Commons2020-08-03 更新00
Targeted Ubiquitination and Degradation of GOLM1 by CC-885 Suppresses Hepatocellular Carcinoma Growth and Metastasis
Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality, necessitating innovative therapeutic approaches. This study demonstrates that the compound CC-885 exerts potent anti-tumor effect
NIAID Data Ecosystem50
DataSheet_1_Liver resection, radiofrequency ablation, and radiofrequency ablation combined with transcatheter arterial chemoembolization for very-early- and early-stage hepatocellular carcinoma: A systematic review and Bayesian network meta-analysis for comparison of efficacy.docx
ObjectiveTo compare the efficacy of liver resection (LR), radiofrequency ablation (RFA), and radiofrequency ablation combined with transcatheter arterial chemoembolization (RFA+TACE) in the treatment
NIAID Data Ecosystem00
